Lucosky Brookman client Conversion Labs, Inc. Closes $3,500,000 Preferred Equity Financing
Conversion Labs, Inc. (the “Company”), (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has completed an equity investment by a select group of private investors and family offices, including investors David Blitzer and Wes Edens, for $3.5 Million. Lucosky Brookman acted as lead counsel for the Company in connection with its sale of 3,500 units (the “Units”), at a purchase price of $1,000 per Unit, each consisting of one share of Series B Convertible Preferred Stock of the Company, par value $0.0001 per share, and a warrant to purchase 2,000 shares of common stock, par value $0.0001 per share of the Company.